LINCOLN, Neb. (AP) — A new startup medical imaging company will use technology developed at the University of Nebraska-Lincoln.
Ground Fluor Pharmaceuticals Inc. will use the technology to help it and other companies better manufacture imaging agents for positron emission tomography, or PET, scans.
A PET scan is a nuclear medicine imaging technique that provides information about the function and metabolism of the body's organs. PET scans are used mainly to study patients with cancer, heart disease and neurodegenerative disorders such as Parkinson's and Alzheimer's.
UNL fluorine chemist Stephen DiMagno discovered a way to improve PET scans, which may also help expand the types of diseases that PET scans can diagnose.
Ground Fluor Pharmaceuticals will house its research and development facility in Lincoln. The company will also have an office in Cambridge, Mass.